ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 151

Molecular Mechanisms of Pathogenic T Cell Resilience in Human Arthritis

Pavanish Kumar1, Jing Yao Leong1, Bhairav Paleja1, Suzan Saidin1, jorg van Loosdregt1, Thaschawee Arkachaisri2, Alessandro Consolaro3, Marco Gattorno4, Alberto Martini5, Gary W Williams6, Ken D Pischel6, Martin Lotz7 and Salvatore Albani8, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2KK Women's and Children's Hospital, Singapore, Singapore, 3Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genova, Italy, 4Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genoa, Italy, 5Pediatric Rheumatology International Trial Organization (PRINTO) Coordinating Centre, Genoa, Italy, 6Scripps Clinic, La Jolla,, California, CA, 7Department of Molecular & Experience Medicine, Scripps Research Institute, LaJolla, CA, 8Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Autoimmunity, autophagy, inflammation and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

T-cell resilience is critical to the immune pathogenesis of human autoimmune arthritis. Autophagy is essential for memory T cell generation and is associated with pathogenesis in rheumatoid arthritis (RA). We have previously described that CD4+ T cells in patients with RA have an increased level of autophagy compared to their healthy controls. Here, we sought to explore at epigenetic and transcriptional levels the concept of persisting increased autophagy as the consequence of “autophagic memory”, as one of the mechanisms conferring resilience to pathogenic T cells, in particular to a subset of CD4+ T cells (CPL: Circulating Pathogenic-like Lymphocytes), which are significantly more represented in patients with active arthritis and patients resistant to therapy with biologics.

Methods:

Autophagy was assessed in CD4+ T cell subsets from autoimmune arthritis patients and healthy subjects using flow cytometry. RNA sequencing and methylation array analysis to understand the molecular mechanism of autophagic memory. Transcription-factor gene regulatory network analysis was built to identify key regulators. qPCR was used to confirm the gene expression level of key regulators.

Results:

We demonstrated “Autophagic memory” as elevated autophagy levels in CD4+ memory T cells compared to CD4+ naive T cells and in Jurkat Human T cell line trained with starvation stress. We then showed increased levels of autophagy in pathogenic CD4+ T cells subsets from autoimmune arthritis patients. Using RNA-sequencing, transcription factor gene regulatory network and methylation analyses we identified MYC as a key regulator of autophagic memory. We validated MYC levels using qPCR and further demonstrated that inhibiting MYC increased autophagy.

Conclusion:

The present study proposes the novel concept of autophagic memory and suggests that autophagic memory confers metabolic advantage to pathogenic T cells from RA and supports its resilience and long term survival. Particularly, suppression of MYC imparted the heightened autophagy levels in pathogenic T cells. These studies have a direct translational valency as they identify autophagy and its metabolic controllers as a novel therapeutic target.


Disclosure: P. Kumar, None; J. Y. Leong, None; B. Paleja, None; S. Saidin, None; J. van Loosdregt, None; T. Arkachaisri, None; A. Consolaro, None; M. Gattorno, None; A. Martini, None; G. W Williams, None; K. D Pischel, None; M. Lotz, None; S. Albani, None.

To cite this abstract in AMA style:

Kumar P, Leong JY, Paleja B, Saidin S, van Loosdregt J, Arkachaisri T, Consolaro A, Gattorno M, Martini A, W Williams G, D Pischel K, Lotz M, Albani S. Molecular Mechanisms of Pathogenic T Cell Resilience in Human Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/molecular-mechanisms-of-pathogenic-t-cell-resilience-in-human-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-mechanisms-of-pathogenic-t-cell-resilience-in-human-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology